Jan 22, 2025
  • 1Colorado State University, Fort Collins;
  • 2Department of Pharmaceutical Chemistry, University of California, San Francisco;
  • 3Department of Biochemistry and Biophysics, University of California, San Francisco;
  • 4Institute for Evolvable Medicines, Oakland, CA, USA;
  • 5Autonomous Therapeutics, Inc., Rockville, MD, USA
Icon indicating open access to content
QR code linking to this content
Protocol CitationRobert TP Williams, Erin Osborne Nishimura, Binyamin Zuckerman, Leor S. Weinberger 2025. Embryo stage C. elegans dissociation for FACS isolation and RNA-seq analysis. protocols.io https://dx.doi.org/10.17504/protocols.io.kxygx3d4wg8j/v1
License: This is an open access  protocol  distributed under the terms of the  Creative Commons Attribution License,  which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: February 07, 2024
Last Modified: January 22, 2025
Protocol  Integer ID: 94856
Keywords: C. elegans, FACS, single cell suspension, cell dissociaiton, embryo stage, intestine, specific cells through fluorescence activated cell sorting, fluorescence activated cell sorting, dissociation for facs isolation, single cell suspension, single cell suspension suitable for isolation, embryo, facs isolation, cell, rna, specific cell, treatment with chitinase, single cell, chitinase
Funders Acknowledgements:
National Institutes of Health
Grant ID: R35GM124877
Bridge to Doctorate at Colorado State University
Grant ID: 1612513
National Science Foundation
Grant ID: 2143849
Webb-Waring Biomedical Research Award
Grant ID: E.O.N.
National Institutes of Health
Grant ID: R37AI109593
EMBO Postdoctoral fellowship
Grant ID: ALTF 388-2021
Abstract
Materials
Before beginning
Chitinase Treatment
Pronase treatment and dissociation
Wash and harvest single cells
Measure approximate cell concentration